A new ten-gene risk fraction model serving as prognostic indicator for clinical outcome of multiple myeloma.

Hu, Ai-Xin; Huang, Zhi-Yong; Liu, Ping; Xiang, Tian; Yan, Shi; Zhang, Li

Hu, Ai-Xin; Huang, Zhi-Yong; Liu, Ping; Xiang, Tian; Yan, Shi; Zhang, Li.

Afiliação

Hu AX; The Department of Orthopedic Surgery, People's Hospital of Three Gorges University, YiChang, Hubei Province, China.
Huang ZY; PuAi Institute, E Dong Healthcare Group, The Central Hospital of Huangshi, Huangshi, Hubei Province, China.
Liu P; Department of Pathology, Shiyan Taihe Hospital, Hubei University of Medicine, Shiyan City, Hubei Province, China.
Xiang T; Department of Clinical Laboratory Center, Central Hospital of Enshi Autonomous Prefecture, Enshi Clinical College of Wuhan University, Enshi, Hubei, China.
Yan S; Department of Emergency, The Affiliated Huai'an Hospital of Xuzhou Medical College and The Second People's Hospital of Huai'an, Huai'an, China. jfmsy@163.com.
Zhang L; Department of Hematology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China. 1310682@tongji.edu.cn.

Tumour Biol ; 2016 Oct 05.

Article em En | MEDLINE | ID: mdl-27709552

Palavras-chave

Genes; Microarray expression profiling; Multiple myeloma; Prognostic indicator; Survival rates

Buscar no Google

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Bases de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Tumour Biol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China

Buscar no Google

Adicionar na Minha BVS

Imprimir

XML

PubMed Links